title: Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
abstract: The variability of serum osteoprotegerin (OPG) and soluble RANKL (sRANKL) along the 24-h cycle was assessed in 20 healthy women. No rhythmic variations of serum OPG, sRANKL or sRANKL/OPG ratio were detected as a group phenomenon. Timing of sampling is unlikely to influence the results of measurements of circulating OPG and sRANKL.
  
  
  BACKGROUND
  Physiological bone turnover shows diurnal variations. The aim of the study was to assess variability of OPG and sRANKL serum levels along the 24-h cycle.
  
  
  METHODS
  Blood was collected from 20 healthy women (median age 31 years, range 25-65 years) at 4-h intervals between 08:00 and 24:00 and at 2-h intervals between 24:00 and 08:00. Serum albumin, cortisol, osteocalcin (OC), C-terminal telopeptide of type I collagen (CTX), OPG and total sRANKL were measured. Temporal variations were assessed by the COSINOR model.
  
  
  RESULTS
  Circadian rhythms of cortisol and albumin documented a normal synchronization within the circadian structure. Serum OC and CTX showed rhythmic variations, peaking at night-time. Rhythmic variations of serum OPG, sRANKL and sRANKL/OPG ratio were not detected as a group phenomenon. On an individual basis, rhythmic changes were detected in ten patients for OPG and eight patients for sRANKL, with very small amplitudes and heterogeneous acrophases.
  
  
  CONCLUSIONS
  The absence of consistent rhythmic variations of circulating OPG and sRANKL levels may reflect the absence of rhythmic variations of their expression in the bone microenvironment. Were this the case, the nocturnal rise of bone resorption should be accounted for by different, not RANKL/OPG-mediated factors. Since circulating OPG and sRANKL may derive from sources other than bone, rhythmicity could be masked by non-rhythmic or non-synchronized rhythmic expression in these sources. Timing of sampling is unlikely to influence the results of measurements of circulating OPG and sRANKL.
authors: Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. andrea.dovio@unito.it
authors: A
authors: A
authors: Dovio
authors: D
authors: D
authors: Generali
authors: M
authors: M
authors: Tampellini
authors: A
authors: A
authors: Berruti
authors: S
authors: S
authors: Tedoldi
authors: M
authors: M
authors: Torta
authors: S
authors: S
authors: Bonardi
authors: M
authors: M
authors: Tucci
authors: G
authors: G
authors: Allevi
authors: S
authors: S
authors: Aguggini
authors: A
authors: A
authors: Bottini
authors: L
authors: L
authors: Dogliotti
authors: A
authors: A
authors: Angeli
mesh_terms: D000328:Adult; D000368:Aged; D016723:Bone Remodeling / Q000502:physiology*; D002940:Circadian Rhythm; D024042:Collagen Type I / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood; D053244:Osteoprotegerin / Q000097:blood*; D053245:RANK Ligand / Q000097:blood*; D012709:Serum Albumin / Q000737:chemistry
chemical_list: D024042:Collagen Type I; D053244:Osteoprotegerin; D053245:RANK Ligand; D012709:Serum Albumin; D015675:Osteocalcin; D006854:Hydrocortisone
references: Biochem Biophys Res Commun. 1998 Apr 17;245(2):382-7
references: 9571159
references: Biochem Biophys Res Commun. 2000 Sep 7;275(3):768-75
references: 10973797
references: J Endocrinol Invest. 2005;28(10 Suppl):14-22
references: 16550717
references: Int J Biochem Cell Biol. 2007;39(6):1077-81
references: 17174136
references: J Bone Miner Res. 2007 Mar;22(3):357-65
references: 17144790
references: Calcif Tissue Int. 1997 May;60(5):419-23
references: 9115158
references: J Clin Endocrinol Metab. 2007 May;92(5):1803-8
references: 17327380
references: J Biol Chem. 2006 Dec 1;281(48):36846-55
references: 17018528
references: Bone. 2002 Jul;31(1):57-61
references: 12110413
references: Bone. 2007 Mar;40(3):723-9
references: 17081815
references: Bone. 2003 Feb;32(2):170-9
references: 12633789
references: Clin Lab. 2003;49(9-10):461-3
references: 14572201
references: Bone. 2002 Jan;30(1):307-13
references: 11792602
references: Biomed Pharmacother. 2005 Oct;59 Suppl 1:S225-8
references: 16275499
references: Cell. 2005 Sep 9;122(5):803-15
references: 16143109
references: Ann Clin Biochem. 2000 Jul;37 ( Pt 4):432-46
references: 10902858
references: Clin Chem. 2003 Dec;49(12):2083-5
references: 14633883
references: Clin Cancer Res. 2002 Jul;8(7):2306-10
references: 12114435
references: Cytokine Growth Factor Rev. 2004 Dec;15(6):457-75
references: 15561602
references: J Clin Endocrinol Metab. 1998 Mar;83(3):751-6
references: 9506720
references: JAMA. 2004 Jul 28;292(4):490-5
references: 15280347
references: Bone. 2002 Jul;31(1):62-9
references: 12110414
references: J Clin Endocrinol Metab. 2005 Nov;90(11):6323-31
references: 16105967
references: Bone. 2007 Jan;40(1):182-8
references: 16935041